Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH

23.58

-0.25(-1.05%)

Updated at October 20 02:30PM

Currency In CNY

Valuation

Market Cap3.19B
Enterprise Value3.06B
P/E Ratio24.28
PEG Ratio1.76
Price/Sales Ratio6.61
Price/Book Ratio2.45
Enterprise/Revenue6.29
Enterprise/EBITDA20.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.27
Operating Margin0.28

Management Effectiveness

Return On Assets0.09
Return On Equity0.1

Income Statement

Revenue555.59M
Revenue/Share3.59
Gross Profit242.32M
EBITDA196.9M
Net Income124.21M
Diluted EPS0.74

Balance Sheet

Total Cash292.69M
Total Cash/Share1.74
Total Debt87.44M
Total Debt/Equity0.05
Current Ratio4.76
Book Value Per Share9.76

Price History

52-Week Change23.73
52-Week High31.13
52-Week Low16.93
Moving Average 50 Days26.89
Moving Average 200 Days24.9

Statistics

Average Volume4.69M
Shares Outstanding167.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.84
Payout Ratio0.01
Last Split Factor7:5
Last Split DateJuly 18, 2023